The global nucleic acid testing market is witnessing unprecedented growth, with a market size of USD 3.7 billion in 2023, driven by a robust compound annual growth rate (CAGR) of 6.8%. By the end of ...

Download this application note to learn how a comprehensive target enrichment panel enables scientists to detect highly divergent viral strains, thereby making NGS a viable approach for viral pathogen ...

Sequins, a newly-funded start-up in the next generation sequencing (NGS) ecosystem, announced today the availability of their first commercial products – the Sequins Metagenomics Core Control and ...

TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has partnered with, ...

Advance quantum information systems through innovative material design. Develop ultrasensitive biosensors for non-invasive ...

TriLink BioTechnologies, a Maravai LifeSciences company and provider of life science reagents and services, has partnered ...

Despite hosting more oncology start-ups, Europe is lagging in the development of cancer technologies, losing the competitive ...

Genetic medicines could treat certain diseases, however, the current delivery systems available—viral vectors and lipid nanoparticles (LNPs)—pose unique challenges for gene therapy applications. For ...

TriLink BioTechnologies, a Maravai LifeSciences company (MRVI), has partnered with, Avantor (AVTR) to expand availability of its innovative ...

Complementary discoveries have the potential to enhance treatment options for antibiotic-resistant infections. Researchers at ...

This study presents TBorNotTB, a CDSS designed to improve TB evaluation and streamline isolation decisions, reducing labor ...